120:(MDS) published a revision of the UPDRS, known as the MDS-UPDRS. The revision became desirable after an MDS-sponsored Task Force on Rating Scales for Parkinson's Disease highlighted the limitations of the original UPDRS. Two major limitations include the lack of consistent anchor among subscales and the low emphasis on the nonmotor features of PD. The modified UPDRS retains the four-scale structure with a reorganization of the various subscales. Score ranges from 0 to 260, with 0 indicating no disability and 260 indicating total disability. The scales are:
88:
Clinicians and researchers alike use the UPDRS and the motor section in particular to follow the progression of a person's
Parkinson's disease. Scientific researchers use it to measure benefits from a given therapy in a more unified and accepted rating system. Neurologists also use it in clinical
482:
Skorvanek, Matej; Martinez-Martin, Pablo; Kovacs, Norbert; Rodriguez-Violante, Mayela; Corvol, Jean-Christophe; Taba, Pille; Seppi, Klaus; Levin, Oleg; Schrag, Anette; Foltynie, Thomas; Alvarez-Sanchez, Mario; Arakaki, Tomoko; Aschermann, Zsuzsanna; Aviles-Olmos, Iciar; Benchetrit, Eve (2017).
271:
Goetz, Christopher G.; Fahn, Stanley; Martinez-Martin, Pablo; Poewe, Werner; Sampaio, Cristina; Stebbins, Glenn T.; Stern, Matthew B.; Tilley, Barbara C.; Dodel, Richard; Dubois, Bruno; Holloway, Robert; Jankovic, Joseph; Kulisevsky, Jaime; Lang, Anthony E.; Lees, Andrew;
96:'s symptoms started with a slight tremor, so his motor score would have been less than 10. For most patients, the "mentation, behavior and mood" scores increase later in the disease, but a subset exists for whom those symptoms develop early on.
154:
Ramaker, Claudia; Marinus, Johan; Stiggelbout, Anne
Margarethe; van Hilten, Bob Johannes (1 September 2002). "Systematic evaluation of rating scales for impairment and disability in Parkinson's disease".
62:
Part II: self-evaluation of the activities of daily life (ADLs) including speech, swallowing, handwriting, dressing, hygiene, falling, salivating, turning in bed, walking, and cutting food
418:
Balestrino, Roberta; Hurtado-Gonzalez, Carlos
Alberto; Stocchi, Fabrizio; Radicati, Fabiana Giada; Chaudhuri, K. Ray; Rodriguez-Blazquez, Carmen; Martinez-Martin, Pablo (2019-11-27).
317:
Movement
Disorder Society Task Force on Rating Scales for Parkinson's Disease (July 2003). "The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations".
276:; LeWitt, Peter A.; Nyenhuis, David; Olanow, C. Warren; Rascol, Olivier; Schrag, Anette; Teresi, Jeanne A.; Van Hilten, Jacobus J.; LaPelle, Nancy (1 January 2007).
561:
278:"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan"
108:
and Schwab and
England activities of daily living scale, although both of these measures are currently included within the UPDRS in modified format.
252:
579:
532:
211:
207:
598:
85:
These are evaluated by interview and clinical observation. Some sections require multiple grades assigned to each extremity.
360:
Sheshadri, Veena; Rowland, Nathan C.; Mehta, Jigesh; Englesakis, Marina; Manninen, Pirjo; Venkatraghavan, Lashmi (2017).
124:
Part I: Nonmotor experiences of daily living: 13 items. Score range: 0–52, 10 and below is mild, 22 and above is severe.
79:
127:
Part II: Motor experiences of daily living: 13 items. Score range: 0–52, 12 and below is mild, 30 and above is severe.
420:"Applications of the European Parkinson's Disease Association sponsored Parkinson's Disease Composite Scale (PDCS)"
244:
536:
117:
603:
92:
Following the UPDRS scores over time provides insight into the patient's disease progression. For instance
49:
41:
130:
Part III: Motor examination: 18 items. Score range: 0–132, 32 and below is mild, 59 and above is severe.
133:
Part IV: Motor complications: 6 items. Score range: 0–24, 4 and below is mild, 13 and above is severe.
362:"Comparison of General and Local Anesthesia for Deep Brain Stimulator Insertion: A Systematic Review"
105:
72:
342:
180:
514:
457:
439:
391:
383:
334:
299:
248:
172:
504:
496:
447:
431:
373:
326:
289:
164:
137:
Each item has 0–4 ratings: 0 (normal), 1 (slight), 2 (mild), 3 (moderate), and 4 (severe).
89:
practice to follow the progression of their patients' symptoms in a more objective manner.
583:
576:
509:
484:
452:
419:
93:
567:
Unified
Parkinson's Disease Rating Scale on Movement Disorders Virtual University site
215:
592:
485:"Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration"
346:
273:
184:
45:
238:
566:
562:
Unified
Parkinson's Disease Rating Scale on National Parkinson Foundation site
435:
443:
387:
518:
461:
395:
338:
303:
176:
378:
361:
500:
330:
294:
277:
168:
240:
Understanding
Parkinson's Disease: A Personal and Professional View
571:
197:
Comprehensive pharmacy review, Leon
Shargel, 6th edition, p. 998.
16:
Rating scale consisting of a conglomerate of other rating scales
30:
used to follow the longitudinal course of
Parkinson's disease
48:
is the most commonly used scale in the clinical study of
65:
Part III: clinician-scored monitored motor evaluation
40:(UPDRS) is used to follow the longitudinal course of
104:
Other rating scales for Parkinson's disease are the
59:
Part I: evaluation of mentation, behavior, and mood
26:
21:
413:
411:
409:
407:
405:
477:
475:
473:
471:
8:
75:staging of severity of Parkinson's disease
533:"Parkinson's Disease Diagnostic Criteria"
508:
451:
377:
366:Canadian Journal of Neurological Sciences
293:
55:The UPDRS is made up of these sections:
38:unified Parkinson's disease rating scale
22:Unified Parkinson's disease rating scale
266:
264:
146:
18:
7:
489:Movement Disorders Clinical Practice
14:
68:Part IV: complications of therapy
214:. 23 March 2009. Archived from
237:Rosenbaum, Richard B. (2006).
212:Parkinson's Disease Foundation
1:
572:Free online UPDRS calculator
208:"Frequently Asked Questions"
80:Schwab and England ADL scale
620:
245:Greenwood Publishing Group
436:10.1038/s41531-019-0097-1
118:Movement Disorder Society
577:UPDRS online calculator
424:npj Parkinson's Disease
535:. BMJ. Archived from
100:Similar rating scales
379:10.1017/cjn.2017.224
106:Hoehn and Yahr scale
599:Parkinson's disease
50:Parkinson's disease
42:Parkinson's disease
582:2018-02-27 at the
501:10.1002/mdc3.12476
319:Movement Disorders
282:Movement Disorders
157:Movement Disorders
539:on 28 August 2021
331:10.1002/mds.10473
295:10.1002/mds.21198
254:978-0-275-99166-1
169:10.1002/mds.10248
34:
33:
611:
549:
548:
546:
544:
529:
523:
522:
512:
479:
466:
465:
455:
415:
400:
399:
381:
357:
351:
350:
314:
308:
307:
297:
268:
259:
258:
234:
228:
227:
225:
223:
204:
198:
195:
189:
188:
151:
19:
619:
618:
614:
613:
612:
610:
609:
608:
589:
588:
584:Wayback Machine
558:
553:
552:
542:
540:
531:
530:
526:
481:
480:
469:
417:
416:
403:
359:
358:
354:
316:
315:
311:
270:
269:
262:
255:
236:
235:
231:
221:
219:
218:on 19 July 2011
206:
205:
201:
196:
192:
153:
152:
148:
143:
114:
102:
17:
12:
11:
5:
617:
615:
607:
606:
604:Medical scales
601:
591:
590:
587:
586:
574:
569:
564:
557:
556:External links
554:
551:
550:
524:
495:(4): 536–544.
467:
401:
372:(6): 697–704.
352:
309:
260:
253:
229:
199:
190:
163:(5): 867–876.
145:
144:
142:
139:
135:
134:
131:
128:
125:
113:
110:
101:
98:
94:Michael J. Fox
83:
82:
76:
73:Hoehn and Yahr
69:
66:
63:
60:
32:
31:
28:
24:
23:
15:
13:
10:
9:
6:
4:
3:
2:
616:
605:
602:
600:
597:
596:
594:
585:
581:
578:
575:
573:
570:
568:
565:
563:
560:
559:
555:
538:
534:
528:
525:
520:
516:
511:
506:
502:
498:
494:
490:
486:
478:
476:
474:
472:
468:
463:
459:
454:
449:
445:
441:
437:
433:
429:
425:
421:
414:
412:
410:
408:
406:
402:
397:
393:
389:
385:
380:
375:
371:
367:
363:
356:
353:
348:
344:
340:
336:
332:
328:
325:(7): 738–50.
324:
320:
313:
310:
305:
301:
296:
291:
287:
283:
279:
275:
274:Leurgans, Sue
267:
265:
261:
256:
250:
246:
242:
241:
233:
230:
217:
213:
209:
203:
200:
194:
191:
186:
182:
178:
174:
170:
166:
162:
158:
150:
147:
140:
138:
132:
129:
126:
123:
122:
121:
119:
116:In 2007, the
111:
109:
107:
99:
97:
95:
90:
86:
81:
77:
74:
70:
67:
64:
61:
58:
57:
56:
53:
51:
47:
43:
39:
29:
25:
20:
541:. Retrieved
537:the original
527:
492:
488:
427:
423:
369:
365:
355:
322:
318:
312:
288:(1): 41–47.
285:
281:
239:
232:
220:. Retrieved
216:the original
202:
193:
160:
156:
149:
136:
115:
103:
91:
87:
84:
54:
46:rating scale
37:
35:
44:. The UPD
593:Categories
222:31 January
141:References
444:2373-8057
430:(1): 26.
388:0317-1671
112:MDS-UPDRS
78:Part VI:
580:Archived
519:30363418
462:31798050
396:28920562
339:12815652
304:17115387
177:12360535
71:Part V:
510:6174385
453:6881347
347:1759369
185:2562332
27:Purpose
517:
507:
460:
450:
442:
394:
386:
345:
337:
302:
251:
183:
175:
543:8 May
343:S2CID
181:S2CID
545:2012
515:PMID
458:PMID
440:ISSN
392:PMID
384:ISSN
335:PMID
300:PMID
249:ISBN
224:2011
173:PMID
36:The
505:PMC
497:doi
448:PMC
432:doi
374:doi
327:doi
290:doi
165:doi
595::
513:.
503:.
491:.
487:.
470:^
456:.
446:.
438:.
426:.
422:.
404:^
390:.
382:.
370:44
368:.
364:.
341:.
333:.
323:18
321:.
298:.
286:22
284:.
280:.
263:^
247:.
243:.
210:.
179:.
171:.
161:17
159:.
52:.
547:.
521:.
499::
493:4
464:.
434::
428:5
398:.
376::
349:.
329::
306:.
292::
257:.
226:.
187:.
167::
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.